0001415889-22-004365.txt : 20220429 0001415889-22-004365.hdr.sgml : 20220429 20220429163051 ACCESSION NUMBER: 0001415889-22-004365 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220428 FILED AS OF DATE: 20220429 DATE AS OF CHANGE: 20220429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DWEK RAYMOND CENTRAL INDEX KEY: 0001231617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 22876151 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4-04292022_040401.xml X0306 4 2022-04-28 0001082554 UNITED THERAPEUTICS Corp UTHR 0001231617 DWEK RAYMOND C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 true false false false Common Stock 2022-04-28 4 M 0 2000 48.11 A 2000 D Common Stock 2022-04-28 4 D 0 2000 179.34 D 0 D Share Tracking Award 48.11 2022-04-28 4 M 0 2000 0 D 2013-06-26 2022-06-26 Common Stock 2000 2000 D This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. /s/ John S. Hess, Jr. under Power of Attorney 2022-04-29